61830-40-8 Usage
Uses
Used in Pharmaceutical Industry:
3,5-Dibromopicolinic acid is used as an intermediate in the synthesis of various pharmaceuticals due to its strong antibacterial and antifungal properties. It aids in the development of antimicrobial agents that can effectively combat resistant strains of bacteria and fungi.
Used in Agrochemical Industry:
In the agrochemical industry, 3,5-dibromopicolinic acid is utilized in the production of herbicides. Its potent antimicrobial properties contribute to the development of effective herbicidal compounds that can control the growth of unwanted plants and protect crops.
Used in Organic Chemistry:
3,5-Dibromopicolinic acid serves as a building block in the creation of heterocyclic compounds in organic chemistry. Its unique structure with bromine atoms at the 3 and 5 positions allows for the synthesis of a wide range of complex organic molecules with diverse applications in various fields.
Used in Antimicrobial Agents Development:
3,5-Dibromopicolinic acid is used as an active ingredient in the development of antimicrobial agents for various applications, including medical, industrial, and environmental settings. Its strong antibacterial and antifungal properties make it a promising candidate for the formulation of effective antimicrobial products.
Check Digit Verification of cas no
The CAS Registry Mumber 61830-40-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,3 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 61830-40:
(7*6)+(6*1)+(5*8)+(4*3)+(3*0)+(2*4)+(1*0)=108
108 % 10 = 8
So 61830-40-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Br2NO2/c7-3-1-4(8)5(6(10)11)9-2-3/h1-2H,(H,10,11)
61830-40-8Relevant academic research and scientific papers
Cyclic compounds
-
, (2008/06/13)
1. A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ═CH— or ═N—, Y is —NH—, —NR4—, —S—, —O—, —CH═N—, —N═CH—, —N═N—, —CH═CH—, etc., R1 is a lower alkoxy group, an amino group, a heterocyclic ring containing N atom(s), or a hydroxy group substituted by a heterocyclic ring containing N atom(s) (each of which is optionally substituted), R2 is a lower alkylamino group which is optionally substituted by an aryl group, a lower alkoxy group which is optionally substituted by an aryl group, a lower alkoxy group substituted by an aromatic heterocyclic ring containing N atom(s), R3 is an aryl group, a heterocyclic ring containing N atom(s), a lower alkyl group, a lower alkoxy group, a cyclo lower alkoxy group, a hydroxy group substituted by a heterocyclic ring containing N atom(s), or an amino group (each of which is optionally substituted), and R3 and a substituent in Y may be combined to form a lactone ring. The compound of the present invention has excellent selective PDE V inhibitory activity and therefore, is useful as a therapeutic or prophylactic drug for treating various diseases due to functional disorders on cGMP-signaling.
